MedPath

MPV/S-2P

Generic Name
MPV/S-2P

Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults

Phase 1
Active, not recruiting
Conditions
COVID-19
Interventions
First Posted Date
2024-06-04
Last Posted Date
2025-02-07
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
60
Registration Number
NCT06441968
Locations
🇺🇸

The Hope Clinic of Emory University, Decatur, Georgia, United States

🇺🇸

NYU Grossman Long Island School of Medicine - Vaccine Center, Mineola, New York, United States

🇺🇸

Baylor College of Medicine, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath